Drug Search Results
More Filters [+]

Pegsunercept

Alternative Names: pegsunercept
Latest Update: 2009-11-26
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: TNF Inhibitor

Novel Mechanism: No

Modality: Large Molecule

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Amgen
Company Location: THOUSAND OAKS CA 91320
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Pegsunercept

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 2: Arthritis, Rheumatoid

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

NCT00037700

P2

Completed

Arthritis, Rheumatoid

None

NCT00111423

P2

Completed

Arthritis, Rheumatoid

None

Recent News Events

Date

Type

Title